Towa Pharmaceutical Co., Ltd.
Important Dates
Towa Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 11, 2026.
| Earnings Date | 11/11/2026 |
Share Statistics
As of March 31, 2026, Towa Pharmaceutical Co., Ltd. has 49.23M shares outstanding.
| Shares Outstanding | 49.23M |
Financial Position
As of March 31, 2026, Towa Pharmaceutical Co., Ltd. maintains a current ratio of 2.76, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.76 |
| Quick Ratio | 0.47 |
| Debt / Equity | 127.31 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 4,821.75 |
Balance Sheet
EURAs of March 31, 2026, Towa Pharmaceutical Co., Ltd. holds 247.00M in cash and equivalents against 1.24B in total debt, resulting in a net debt position of 909.90M. Total book value stands at 970.97M, with working capital of 929.39M providing operational flexibility.
| Cash & Cash Equivalents | 247.00M |
| Total Debt | 1.24B |
| Net Debt | 909.90M |
| Equity (Book Value) | 970.97M |
| Book Value Per Share | 19.72 |
| Working Capital | 929.39M |
Stock Splits
Towa Pharmaceutical Co., Ltd.'s most recent stock split took place on March 27, 2019 with a 1:3 split ratio.
| Last Split Date | 3/27/2019 |
| Split Ratio | 1:3 |